This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Ajou University Industry-Academic Cooperation Foundation, University-Industry Cooperation Group of Kyung Hee University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 388 
1 out of 639 Years Active: 2026
Title: Mahesh Chandra Patra: Innovator in Autoimmune Disease Therapeutics
Introduction
Mahesh Chandra Patra is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating autoimmune diseases. With a total of 2 patents, his work focuses on innovative therapeutic agents that target specific signaling pathways.
Latest Patents
Patra's latest patents include a small molecule compound that inhibits the signal transmission path of TLR7 and TLR9. This compound, described as a chemical formula, plays a crucial role in blocking the toll-like receptor (TLR) signaling pathway. The novel compound is designed to inhibit TNF-α secretion by affecting the expression and activation of NF-κB- and MAPK-related proinflammatory genes. This innovation has potential applications in treating various autoimmune diseases, such as systemic lupus erythematosus, psoriasis, and psoriatic arthritis. Additionally, he has developed a small molecule TNF-α inhibitor that specifically binds to the binding cavity of a TNF-α homodimer, preventing the formation of a TNF-α homotrimer. This compound is expected to be more effective and less toxic than existing TNF inhibitors, offering a promising avenue for alleviating chronic systemic inflammatory states.
Career Highlights
Throughout his career, Mahesh Chandra Patra has worked with esteemed institutions, including the Ajou University Industry-Academic Cooperation Foundation and the University-Industry Cooperation Group of Kyung Hee University. His research has been pivotal in advancing the understanding and treatment of inflammatory diseases.
Collaborations
Patra has collaborated with notable colleagues, including Sang Dun Choi and Maria Batool. These partnerships have contributed to the success of his research and the development of innovative therapeutic solutions.
Conclusion
Mahesh Chandra Patra's contributions to the field of autoimmune disease therapeutics highlight his role as a leading inventor. His innovative compounds and research efforts are paving the way for new treatment options that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile